Table 1.
Comparison of Baseline Characteristics by Baseline Cataract Status (n = 535 Patients, 1070 Eyes)
| Patient characteristics | Cataract Status (1070 Eyes) | P-value | ||
|---|---|---|---|---|
| No History (n = 646 eyes) |
On-going (n = 244 eyes) |
Pseudophakic/Aphakic (n= 180 eyes) |
||
| Age (years): Mean (SD) | 52.0 (12.5) | 64.8 (7.2) | 70.2 (8.0) | <0.0001 |
| Race: n (%) | <0.0001 | |||
| White | 445 (68.9%) | 203 (83.2%) | 148 (82.2%) | |
| Black | 78 (12.1%) | 28 (11.5%) | 22 (12.2%) | |
| Asian | 30 (4.6%) | 4 (1.6%) | 4 (2.2%) | |
| Other | 15 (2.4%) | 5 (2.0%) | 4 (2.2%) | |
| Unable to answer | 78 (12.1%) | 4 (1.6%) | 2 (1.1%) | |
| Ethnicity: Hispanic or Latino: n (%) | 116 (18.0%) | 13 (5.3%) | 7 (3.9%) | <0.0001 |
| Gender: Female: n (%) | 507 (78.5%) | 210 (86.1%) | 151 (83.9%) | 0.07 |
| Cigarette smoking | 0.03 | |||
| Never | 461 (71.4%) | 160 (65.6%) | 113 (62.8%) | |
| Former | 148 (22.9%) | 73 (29.9%) | 63 (35.0%) | |
| Current | 37 (5.7%) | 11 (4.5%) | 4 (2.2%) | |
| Rosacea (facial): n (%) | 112 (17.3%) | 62 (25.4%) | 44 (24.4%) | 0.045 |
| Sjögren’s syndrome met 2012ACR criteria: n (%) | 58 (9.0%) | 25 (10.2%) | 21 (11.7%) | 0.61 |
| Self-reported Peripheral vascular disease: n (%) | 45 (7.0%) | 13 (5.3%) | 18 (10.0%) | 0.85 |
| Self-reported Thyroid dysfunction: n (%) | 101 (15.6%) | 42 (17.2%) | 45 (25.0%) | 0.15 |
| Self-reported Hypertension: n (%) | 124 (19.2%) | 92 (37.7%) | 82 (45.6%) | <0.0001 |
| Self-reported Diabetes: n (%) | 48 (7.4%) | 43 (17.6%) | 23 (12.8%) | 0.04 |
| Self-reported Rheumatoid arthritis: n (%) | 57 (8.8%) | 21 (8.6%) | 16 (8.9%) | 0.37 |
| Self-reported Irritable Bowel: n (%) | 56 (8.7%) | 20 (8.2%) | 12 (6.7%) | 0.83 |
| Self-reported Osteoarthritis: n (%) | 108 (16.7%) | 78 (32.0%) | 82 (45.6%) | <0.0001 |
| Self-reported Hypercholesterolemia: n (%) | 143 (22.1%) | 109 (44.7%) | 90 (50.0%) | <0.0001 |
| Depression*: n (%) | 108 (16.7%) | 30 (12.3%) | 30 (16.7%) | 0.58 |
Notes: *Defined as mental component score ≤42. Bold values indicate statistical significance (P<0.05).